LEVOFLOXACIN eye drops solution
Product Description
Rafarm S.A
-
Country/Region:Greece
-
On CPHI since:2015
Rafarm S.A
-
Country/Region:Greece
-
On CPHI since:2015
More Products from Rafarm S.A (38)
-
Product ILOPROST nebulizer solution
Strength: 10 mcg/ml; 20 mcg/ml Presentation: ampoules, 1 ml & 2 ml Therapeutic area: Pulmonary hypertension Innovator: Ventavis (Bayer) -
Product IRON SUCROSE COMPLEX solution for injection/concentrate solution for infusion
Strength: 20 mg Iron/ml Presentation: ampoules, 5 ml & vials, 5 ml Therapeutic area: Iron Deficiency Innovator: Venofer (Vifor) -
Product LATANOPROST + TIMOLOL eye drops solution
Strength: (50 mcg+5 mg)/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalacom (Pfizer) -
Product LATANOPROST eye drops solution
Strength: 50 mcg/ml Presentation: vial, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalatan (Pfizer) -
Product LATANOPROST PRESERVATIVE FREE eye drops solution
Strength: 50 mcg/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Xalatan (Pfizer) -
Product LEVOCARNITINE solution for injection
Strength: 1 g/5 ml; 2 g/5 ml Presentation: ampoules, 5 ml Therapeutic area: Carnitine Deficiency Innovator: Carnitor (Sigma-Tau) -
Product LEVOFLOXACIN PRESERVATIVE FREE eye drops solution
Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial external ocular infections Innovator: Oftaquix (Santen) -
Product OLOPATADINE eye drops solution
Strength: 1 mg/ml Presentation: vials, 5 ml Therapeutic area: Allergic Conjunctivitis Innovator: Opatanol (Alcon) -
Product PALONOSETRON solution for injection
Strength: 250 mcg/5ml Presentation: vials, 5 ml Therapeutic area: Acute Nausea & Vomiting Innovator: Aloxi (Helsinn Birex) -
Product PARICALCITOL soft gel capsules
Strength: 1 mcg/cap; 2 mcg/cap; 4 mcg/cap Therapeutic area: Secondary Hyperparathyroidism Innovator: Zemplar (Abbott) -
Product PARICALCITOL solution for injection
Strength: 2 mcg/ml; 5 mcg/ml Presentation: ampoules, 1 ml (2 mcg/ml & 5 mcg/ml) & 2 ml (5 mcg/ml); vials, 1 ml (2 mcg/ml & 5 mcg/ml) & 2 ml (5 mcg/ml) Therapeutic area: Secondary Hyperparathyroidism Innovator: Zemplar (Abbott) -
Product PRAMIPEXOLE tablets
Strength: 0.088 mg/tab; 0.18 mg/tab; 0.35 mg/tab; 0.7 mg/tab Therapeutic area: Idiopathic Parkinson's Disease & Idiopathic restless legs syndrome Innovator: Mirapexin (Boehringer Ingelheim)
